Drug Utilization Review Board

Regulatory
November 4, 2024
  • Twitter
  • Facebook
  • Google+
  • Linkedin
Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs. Members: Alejandro D. Kudisch, M.D., D.F. A.P.A. (McAllen) (Chair) Jennifer Fix, Pharm. D (Burleson) (Vice-chair) Marlo Brawner, M.D. (Livingston) Dominique Brewster, Pharm.D, BCPS, BCGP, AAHIVP (Houston) Manuel Cano Rivera, M.D., F.A.A.P. (Corpus Christi) Heather Holmes, M.D. (Amarillo) Term ends Aug. 31, 2024 Sarah E. Kubes, Pharm. D. (San Antonio) Term ends Aug. 31, 2024 Jill N. Lester, Pharm. D. (Dallas) Jia Lin, M.D., M.P.H. (Houston) Brigetta Martinez, Pharm. D., BCPPS, MASPHM (Edinburg) Richard Noel, M.D. (Spring) Kim Pham, D.O. (Dallas) Term ends Aug. 31, 2023 Joshua R. Tonche-Johns, Pharm. D. (Richardson) Term ends

Subscribe to gain full access to all of our must-have reports and videos

OR

Log in